Skip to main content
. 2019 Sep 23;10:291. doi: 10.1186/s13287-019-1385-8

Fig. 8.

Fig. 8

A proposed model showing the mechanism of action of UC/PL-MSCs on TGF-β1-induced fibrogenic activation in human primary intestinal myofibroblasts. TGF-β1 induces expression of Procol1A1, FN, and α-SMA by activating the MRTF-A/SRF signaling and Smad2/3. UC/PL-MSCs inhibit TGF-β1-induced fibrogenic responses by blocking the RhoA/MRTF-A/SRF signaling and Smad2/3